This analysis revealed that the mRNA level of CEBPA in AML cells from patients was significantly lower than that in healthy controls, as we previously reported [23], whereas the mRNA level of DDIT3 was significantly higher in AML cells (Fig. 1C). This evidence concerns the gene DDIT3 and acute myeloid leukemia.